Insider trading

Period: 12 months Stock: VCYT Minimum amount: $100K × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

30 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

30 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

30 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

30 decisions over 12 months Remove this filter
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
30 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
30 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

30 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
21 Sep 2026
Leite John Global Chief Commercial Off
Sold on a plan
$160.60K 4,015 at 40.00
3.1%
Planned (10b5-1)
14 Sep 2026
Holstein Jens Director
Sold on a plan
$204.75K 5,000 at 40.95
15.4%
Planned (10b5-1)
4 Sep 2026
Febbo Phillip G. Chief Scientific & Med Officer
Sold on a plan 2×
$564.41K 13,110 at 43.05
9.0%
Planned (10b5-1)
4 Sep 2026
Chambers Rebecca Chief Financial Officer
Sold on a plan 2×
$157.39K 3,652 at 43.10
2.2%
Planned (10b5-1)
4 Sep 2026
McGuire Annie EVP, General Counsel
Sold on a plan 2×
$140.21K 3,254 at 43.09
2.4%
Planned (10b5-1)
18 Jun 2026
EASTHAM KARIN Director
Sold on a plan 2×
$197.23K 3,729 at 52.89
19.8%
Planned (10b5-1)
4 Jun 2026
Stapley Marc Chief Executive Officer
Sold on a plan
$6.92M 138,051 at 50.12
23.9%
Planned (10b5-1)
4 Jun 2026
Leite John Global Chief Commercial Off
Sold on a plan
$699.73K 13,975 at 50.07
9.6%
Planned (10b5-1)
4 Jun 2026
Chambers Rebecca Chief Financial Officer
Sold on a plan 2×
$177.08K 3,561 at 49.73
2.0%
Planned (10b5-1)
4 Jun 2026
McGuire Annie EVP, General Counsel
Sold on a plan 2×
$158.04K 3,176 at 49.76
2.3%
Planned (10b5-1)
22 May 2026
Wygant Jonathan VP, Chief Accounting Officer
Sold at will
$1.09M 24,000 at 45.40
34.6%
Not planned
20 May 2026
EPSTEIN ROBERT S Director
Sold on a plan
$440.13K 10,000 at 44.01
16.0%
Planned (10b5-1)
6 May 2026
McGuire Annie SVP, General Counsel
Sold on a plan 2×
$398.21K 10,204 at 39.03
6.6%
Planned (10b5-1)
4 Mar 2026
Stapley Marc Chief Executive Officer
Sold on a plan 2×
$1.64M 45,523 at 35.97
11.3%
Planned (10b5-1)
4 Mar 2026
Chambers Rebecca Chief Financial Officer
Sold on a plan 2×
$662.87K 18,341 at 36.14
12.3%
Planned (10b5-1)
4 Mar 2026
McGuire Annie SVP, General Counsel
Sold on a plan 2×
$236.72K 6,658 at 35.55
6.6%
Planned (10b5-1)
4 Mar 2026
Leite John Chief Commercial Officer-CLIA
Sold on a plan
$185.08K 5,260 at 35.19
4.7%
Planned (10b5-1)
2 Mar 2026
Febbo Phillip G. Chief Scientific & Med Officer
Sold on a plan
$485.43K 13,425 at 36.16
10.3%
Planned (10b5-1)
16 Dec 2025
McGuire Annie SVP, General Counsel
Sold on a plan 2×
$463.20K 10,739 at 43.13
13.7%
Planned (10b5-1)
5 Dec 2025
EASTHAM KARIN Director
Sold on a plan 3×
$908.92K 20,000 at 45.45
59.6%
Sold half or more
4 Dec 2025
Chambers Rebecca Chief Financial Officer
Sold on a plan 2×
$621.96K 13,278 at 46.84
10.8%
Planned (10b5-1)
4 Dec 2025
Stapley Marc Chief Executive Officer
Sold on a plan 2×
$361.08K 7,668 at 47.09
2.4%
Planned (10b5-1)
25 Nov 2025
Leite John Chief Commercial Officer-CLIA
Sold on a plan
$140.40K 2,808 at 50.00
3.2%
Planned (10b5-1)
20 Nov 2025
Holstein Jens Director
Sold on a plan 3×
$423.56K 10,000 at 42.36
26.9%
Planned (10b5-1)
10 Nov 2025
Wygant Jonathan VP, Chief Accounting Officer
Sold at will
$215.98K 5,102 at 42.33
11.6%
Not planned
7 Nov 2025
Wygant Jonathan VP, Chief Accounting Officer
Sold at will
$233.93K 5,818 at 40.21
11.7%
Not planned
5 Nov 2025
JONES EVAN/ FA Director
Sold on a plan 6×
$1.95M 43,196 at 45.06
58.6%
Sold half or more
5 Nov 2025
EASTHAM KARIN Director
Sold on a plan
$387.19K 9,674 at 40.02
41.6%
Planned (10b5-1)
5 Nov 2025
Chambers Rebecca Chief Financial Officer
Sold on a plan
$287.00K 7,000 at 41.00
5.3%
Planned (10b5-1)
5 Nov 2025
McGuire Annie SVP, General Counsel
Sold on a plan
$258.64K 6,466 at 40.00
7.2%
Planned (10b5-1)
Showing 1–30 of 30.